Market News
Jazz Pharma Buys Actio Biosciences In Major Rare Epilepsy Deal
Jazz Pharmaceuticals just dropped $820 million on Actio Biosciences, locking in a promising oral therapy for a rare form of...
11/08/2026
4 views